István Bitter

12.1k total citations · 5 hit papers
156 papers, 5.1k citations indexed

About

István Bitter is a scholar working on Psychiatry and Mental health, Cognitive Neuroscience and Clinical Psychology. According to data from OpenAlex, István Bitter has authored 156 papers receiving a total of 5.1k indexed citations (citations by other indexed papers that have themselves been cited), including 112 papers in Psychiatry and Mental health, 37 papers in Cognitive Neuroscience and 27 papers in Clinical Psychology. Recurrent topics in István Bitter's work include Schizophrenia research and treatment (70 papers), Attention Deficit Hyperactivity Disorder (35 papers) and Bipolar Disorder and Treatment (31 papers). István Bitter is often cited by papers focused on Schizophrenia research and treatment (70 papers), Attention Deficit Hyperactivity Disorder (35 papers) and Bipolar Disorder and Treatment (31 papers). István Bitter collaborates with scholars based in Hungary, United States and Germany. István Bitter's co-authors include Pál Czobor, Viktória Simon, Sára Bálint, Ágnes Mészáros, Sarolta Komlósi, Jan Volavka, Martín Dossenbach, János Réthelyi, Michael J. Detke and Curtis G. Wiltse and has published in prestigious journals such as New England Journal of Medicine, The Lancet and PLoS ONE.

In The Last Decade

István Bitter

143 papers receiving 4.9k citations

Hit Papers

Prevalence and correlates of adult attention-deficit hype... 2009 2026 2014 2020 2009 2022 2021 2021 2023 250 500 750 1000

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
István Bitter Hungary 34 3.7k 1.5k 975 726 684 156 5.1k
John Lauriello United States 38 2.1k 0.6× 1.9k 1.3× 1.0k 1.0× 411 0.6× 686 1.0× 95 4.9k
Robert Goldman United States 36 3.9k 1.0× 1.4k 0.9× 1.2k 1.2× 477 0.7× 548 0.8× 100 5.4k
Alkomiet Hasan Germany 42 2.3k 0.6× 1.9k 1.3× 1.1k 1.1× 594 0.8× 372 0.5× 215 6.1k
Myrto Samara Germany 25 4.0k 1.1× 763 0.5× 969 1.0× 855 1.2× 639 0.9× 80 5.9k
A. Carlo Altamura Italy 40 2.9k 0.8× 777 0.5× 1.3k 1.4× 975 1.3× 523 0.8× 173 5.2k
H.‐J. Möller Germany 36 2.4k 0.7× 767 0.5× 689 0.7× 660 0.9× 384 0.6× 140 4.2k
Bernard Sabbe Belgium 46 2.3k 0.6× 1.8k 1.2× 1.7k 1.8× 659 0.9× 1.1k 1.6× 246 6.4k
Ronald N. Marcus United States 42 5.2k 1.4× 1.1k 0.7× 1.2k 1.2× 1.4k 2.0× 340 0.5× 87 6.5k
Julia Lappin Australia 37 2.2k 0.6× 975 0.7× 1.3k 1.3× 447 0.6× 346 0.5× 153 4.8k
Larry Alphs United States 36 3.8k 1.0× 584 0.4× 1.1k 1.1× 921 1.3× 693 1.0× 174 5.2k

Countries citing papers authored by István Bitter

Since Specialization
Citations

This map shows the geographic impact of István Bitter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by István Bitter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites István Bitter more than expected).

Fields of papers citing papers by István Bitter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by István Bitter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by István Bitter. The network helps show where István Bitter may publish in the future.

Co-authorship network of co-authors of István Bitter

This figure shows the co-authorship network connecting the top 25 collaborators of István Bitter. A scholar is included among the top collaborators of István Bitter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with István Bitter. István Bitter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wagner, Elias, Vladislav Yakimov, Silvana Galderisi, et al.. (2025). Developing the EPA guidance of pharmacological treatment of schizophrenia – results of a Delphi process. European Psychiatry. 68(1). e26–e26.
4.
McIntyre, Roger S., István Bitter, Jozefien Buyze, et al.. (2024). Safety and tolerability of esketamine nasal spray versus quetiapine extended release in patients with treatment resistant depression. European Neuropsychopharmacology. 85. 58–65. 12 indexed citations
5.
Bitter, István, György Szekeres, Qian Cai, et al.. (2024). Mortality in patients with major depressive disorder: A nationwide population-based cohort study with 11-year follow-up. European Psychiatry. 67(1). e63–e63. 4 indexed citations
6.
Reif, Andreas, István Bitter, Jozefien Buyze, et al.. (2023). Esketamine Nasal Spray versus Quetiapine for Treatment-Resistant Depression. New England Journal of Medicine. 389(14). 1298–1309. 110 indexed citations breakdown →
8.
Kirkpatrick, Brian, Alex S. Cohen, István Bitter, & Gregory P. Strauss. (2021). Primary Negative Symptoms: Refining the Research Target. Schizophrenia Bulletin. 47(5). 1207–1210. 3 indexed citations
9.
Takács, Péter, et al.. (2019). Comparative effectiveness of second generation long-acting injectable antipsychotics based on nationwide database research in Hungary. PLoS ONE. 14(6). e0218071–e0218071. 17 indexed citations
10.
Bitter, István, et al.. (2018). A büntetőeljárásban alkalmazható agyi ujjnyomat (brain fingerprinting) vallomás-ellenőrzési módszer, és annak neurobiológiai alapja, a P300 agyhullám. 18(2). 53–67–53–67. 1 indexed citations
11.
Bálint, Sára, et al.. (2018). Alterations in resting-state gamma activity in patients with schizophrenia: a high-density EEG study. European Archives of Psychiatry and Clinical Neuroscience. 269(4). 429–437. 46 indexed citations
12.
Jakovljević, Miro, Vlado Jukić, Kaire Aadamsoo, et al.. (2016). Schizophrenia causes significant burden to patients' and caregivers' lives.. PubMed. 28(2). 104–10. 24 indexed citations
13.
Huerta‐Ramos, Elena, Zsolt Unoka, Eva Grasa, et al.. (2016). Measuring Users’ Receptivity Toward an Integral Intervention Model Based on mHealth Solutions for Patients With Treatment-Resistant Schizophrenia (m-RESIST): A Qualitative Study. JMIR mhealth and uhealth. 4(3). e112–e112. 16 indexed citations
14.
Jakovljević, Miro, Vlado Jukić, Kaire Aadamsoo, et al.. (2016). Treatment patterns of schizophrenia based on the data from seven Central and Eastern European Countries.. PubMed. 28(3). 234–242. 8 indexed citations
15.
Bitter, István, et al.. (2015). Treatment adherence and insight in schizophrenia.. PubMed. 30(1). 18–26. 31 indexed citations
16.
Bitter, István, et al.. (2013). Comparative effectiveness of depot and oral second generation antipsychotic drugs in schizophrenia: A nationwide study in Hungary. European Neuropsychopharmacology. 23(11). 1383–1390. 29 indexed citations
17.
Bitter, István & Tamás Kurimay. (2012). State of psychiatry in Hungary. International Review of Psychiatry. 24(4). 307–313. 8 indexed citations
18.
Bitter, István, et al.. (2011). Adverse reactions to duloxetine in depression. Expert Opinion on Drug Safety. 10(6). 839–850. 28 indexed citations
19.
Simon, Viktória, et al.. (2007). [Detailed review of epidemiologic studies on adult Attention Deficit/Hyperactivity Disorder (ADHD)].. PubMed. 22(1). 4–19. 10 indexed citations
20.
Bitter, István. (2005). [Antipsychotic treatment and metabolic syndrome. Consensus meeting of the Metabolic Working Group of the Hungarian Diabetes Society and the Hungarian Psychiatric Collegium].. PubMed. 20(4). 312–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026